Results 321 to 330 of about 222,667 (349)
Some of the next articles are maybe not open access.

[Dalbavancin: pharmacokinetic and pharmacodynamic parameters].

Enfermedades infecciosas y microbiologia clinica, 2018
Dalbavancin is a new lipoglycopeptide antibiotic whose structure influences its pharmacokinetic profile. It is not absorbed after oral administration and is therefore administered intravenously. It is distributed through intracellular fluid, reaching adequate concentrations in the skin, bone, blister fluid and synovial fluid.
José Ramón, Azanza   +2 more
openaire   +1 more source

Noninvasive chemical methods of estimating pharmacokinetic parameters

Pharmacology & Therapeutics, 1982
Two noninvasive methods have been advocated for pharmacokinetic and bioavailability studies. The measurement of the salivary and urinary excretion of drugs and their metabolites may avoid sampling blood, particularly in introductory studies. The measurement of the salivary concentrations of drugs is of most value in studies on compounds which are ...
openaire   +2 more sources

Some pharmacokinetic parameters of ampicyline.

Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina, 1990
Artykuł w: Annales Universitatis Mariae Curie-Skłodowska. Sectio D, Medicina Vol. 40, 22 (1985), strony 137-140 ; tytuł równoległy: Niektóre parametry farmakokinetyczne ampicyliny ; tytuł równoległy: Nekotorye farmakokinetičeskie parametry ampicillina ; Streszczenia w językach polskim, rosyjskim.
Klonowski, Stanisław.   +2 more
openaire   +1 more source

Integrative oncology: Addressing the global challenges of cancer prevention and treatment

Ca-A Cancer Journal for Clinicians, 2022
Jun J Mao,, Msce   +2 more
exaly  

Ethnic effects on pharmacokinetic parameters

1994
1. So-called ethnic differences in the efficacy and safety of drugs have been a major hindrance for the mutual acceptance of foreign clinical data. The Japanese Ministry of Health and Welfare therefore analysed pharmacokinetic parameters for the same medicines approved in different countries, in order to assess genetic influences on drug metabolism.
openaire   +1 more source

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Cynthia Morata-Tarifa   +1 more
exaly  

Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma

Ca-A Cancer Journal for Clinicians, 2020
Aaron J Grossberg   +2 more
exaly  

Oral complications of cancer and cancer therapy

Ca-A Cancer Journal for Clinicians, 2012
Joel B Epstein   +2 more
exaly  

The financial burden and distress of patients with cancer: Understanding and stepping‐up action on the financial toxicity of cancer treatment

Ca-A Cancer Journal for Clinicians, 2018
Pricivel M Carrera   +2 more
exaly  

Home - About - Disclaimer - Privacy